HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial

Abstract Background Radiotherapy (RT) is the standard of care for most advanced head and neck squamous cell carcinoma (HNSCC) and results in an unfavorable 5-year overall survival of 40%. Despite strong biological rationale, combining RT with immune checkpoint inhibitors does not result in a surviva...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Joris B. W. Elbers, Pascal A. Gunsch, Reno Debets, Stijn Keereweer, Esther van Meerten, Jaap Zindler, Yvette van Norden, Mischa S. Hoogeman, Gerda M. Verduijn, Michiel Kroesen, Remi A. Nout
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Subjects:	Hypofractionation Radiotherapy HNSCC Proton therapy Immune system Immunotherapy
Online Access:	https://doi.org/10.1186/s12885-023-11031-w